Among all approved small molecule drugs worldwide from 1981 to 2014 (Drug Development), more than 50% of them are of Bacterial natural products (NPs) origin or contain an NP pharmacophore Newman & Cragg 2016 J. Nat. Prod. 79: 629–661
see also:Actinomycetia
